Attitudes of Irish patients with chronic pain towards medicinal cannabis
Medicinal cannabis use is topical in the media in Ireland. A recent Health Products Regulatory Authority review, however, has recommended against its use for patients with chronic pain. This is despite evidence for its effectiveness in this patient’s cohort and the inadequate pain management of these patients.
The aim of this study was to evaluate the attitudes of Irish patients with chronic pain towards medicinal cannabis.
After institutional ethics committee approval, a 12-item questionnaire (excluding demographics) was randomly assigned to patients attending a chronic pain clinic (University Hospital Limerick). The questionnaire was designed to incorporate patient’s attitudes on a variety of medicinal cannabis related topics.
Ninety-six adult patients were surveyed. 88.54% agreed that cannabis should be legalised for chronic pain medicinal purposes. 80.21% believed it would have health benefits for them and 73.96% agreed it would be socially acceptable to use cannabis for this purpose. 33.33% perceived cannabis to be addictive while 68.75% would be willing to try it if prescribed by a medical professional.
The study highlights the attitudes of chronic pain patients in Ireland towards medicinal cannabis. It shows their desire to have medical cannabis legalised for chronic pain and that they view it as a reasonable pain management option.
KeywordsAttitudes Cannabis Chronic pain
Compliance with ethical standards
The study protocol was approved by the research ethics committee of University Limerick Hospitals Group, Mid-West Region.
Conflict of interest
- 5.Department of Health. Minister Harris announces ‘pivotal step’ on Medicinal Cannabis Access Programme [press release]. 2017. [Accessed: 15/12/2017] [Available from: http://health.gov.ie/blog/press-release/minister-harris-announces-pivotal-step-on-medicinal-cannabis-access-programme-prescribers-patients-and-pharmacists-to-draw-up-guidance-for-the-safe-use-of-cannabis-based-treatment/]
- 6.Health Products Regulatory Authority. Cannabis for medical use—a scientific review 2017 [Accessed: 15/12/2017] [Available from: https://www.hpra.ie/docs/default-source/publications-forms/newsletters/cannabis-for-medical-use---a-scientific-review.pdf?sfvrsn=7]
- 8.Breivik H, Collett B, Ventafridda V et al (2016) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10(4):287–333Google Scholar
- 9.Khelemsky Y, Goldberg AT, Hurd YL, Winkel G, Ninh A, Qian L, Oprescu A, Ciccone J, Katz DJ (2017) Perioperative patient beliefs regarding potential effectiveness of marijuana (cannabinoids) for treatment of pain: a prospective population survey. Reg Anesth Pain Med 42(5):652–659. https://doi.org/10.1097/AAP.0000000000000654 Google Scholar
- 12.Single E, Christie P, Ali R (2000) The impact of cannabis decriminalisation in Australia and the United States. J Public Health Policy 21(2):157–186Google Scholar
- 13.Crowley D, Collins C, Delargy I et al (2017) Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey. Harm Reduct J 14(1):4Google Scholar
- 21.Kahan M, Srivastava A, Spithoff S et al (2014) Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations. Can Fam Physician 60(12):1083–1090Google Scholar
- 22.Serpell M, Ratcliffe S, Hovorka J et al (2014) A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. Eur J Pain 18(7):999–1012Google Scholar
- 24.Jones RT, Benowitz NL, Herning RI (1981) Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 21 (8–9 Suppl):143s–152sGoogle Scholar
- 27.Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M et al (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370(9584):319–328Google Scholar
- 28.Vicente J, Wiessing L (2007) European Monitoring Centre for Drugs and Drug Addiction annual report 2007: positive assessment of HIV in IDUs though hepatitis C still very high. Euro Surveill 12(11):E071122.6Google Scholar
- 29.Menghrajani P, Klaue K, Dubois-Arber F et al (2005) Swiss adolescents’ and adults’ perceptions of cannabis use: a qualitative study. Health Educ Res 20(4):476–484Google Scholar
- 30.Colorado Department of Public Health and Environment. The Colorado Medical Marijuana Registry 2017. [Accessed 15/12/2017] [Available from: https://www.colorado.gov/pacific/cdphe/2017-medical-marijuana-registry-statistics]
- 32.Whiting PF, Wolff RF, Deshpande S, di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen J (2015) Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313(24):2456–2473. https://doi.org/10.1001/jama.2015.6358 Google Scholar